Hallett; Allan

Patent Applications and Registrations

Patent applications and USPTO patent grants for Hallett; Allan.The latest application filed is for "1,2,4-thiazolidin-3-one derivatives and their use in the treatment of cancer".

Company Profile

0.7.7

Hallett; Allan - Welwyn Garden City GB
Hallett; Allan - Wellwyn Garden City GB
Hallett; Allan - London GB
Hallett; Allan - Horsham GB
Hallett; Allan - West Sussex GB
Hallett; Allan - Cheam GB2
Hallett; Allan - Wembley GB2

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
1,2,4-thiazolidin-3-one derivatives and their use in the treatment of cancer Grant 9,675,596 - Westman , et al. June 13, 2	2017-06-13
1,2,4-thiazolidin-3-one Derivatives And Their Use In The Treatment Of Cancer App 20160128993 - Westman; Jacob ; et al.	2016-05-12
1,2,4-thiazoloidin-3-one derivatives and their use in the treatment of cancer Grant 9,162,994 - Westman , et al. October 20, 2	2015-10-20
1,2,4-thiazoloidin-3-one Derivatives And Their Use In The Treatment Of Cancer App 20120183537 - Westman; Jacob ; et al.	2012-07-19
Fused pyridine derivatives for use as vanilloid receptor antagonists for treating pain Grant 7,915,264 - Culshaw , et al. March 29, 2	2011-03-29
Compounds and compositions useful as cathepsin S inhibitors Grant 7,704,996 - Hart , et al. April 27, 2	2010-04-27
Compounds And Compositions Useful As Cathepsin S Inhibitors App 20090048230 - Hart; Terance William ; et al.	2009-02-19
Quinazolinone Derivatives Useful As Anti-hyperalgesic Agents App 20080293939 - Culshaw; Andrew James ; et al.	2008-11-27
2-Cyanopyrrolopyrimidines and pharmaceutical uses thereof App 20060247251 - Buxton; Francis Paul ; et al.	2006-11-02
Quinazolinone derivatives useful as anti-hyperalgesic agents App 20060154942 - Culshaw; Andrew James ; et al.	2006-07-13
Fused pyridine derivatives for use as vanilloid receptor antagonists for treating pain App 20040138454 - Culshaw, Andrew James ; et al.	2004-07-15
Enzyme inhibitors Grant 4,650,661 - Szelke , et al. March 17, 1	1987-03-17
Enzyme inhibitors Grant 4,424,207 - Szelke , et al. January 3, 1	1984-01-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.